TBIO
Translate Bio Inc
Halal Rating :
Last Price
$3.31
Last updated:
Market Cap
-
7D Change
794.59%
1 Year Change
915.34%
Company Overview
Industries
Exchange
Next Earnings Date
Translate Bio was a clinical-stage messenger RNA (mRNA) therapeutics company that developed treatments for diseases caused by protein or gene dysfunction. The company was acquired by Sanofi in 2021, and its operations were integrated into Sanofi's mRNA Center of Excellence.
Sanofi is now a global biopharmaceutical company focused on human health, developing, manufacturing and distributing therapeutic solutions with a focus on specialty care, vaccines, and general medicines.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2024 | $1.55m | $13.26m | - | $214000.0 | 0.00% | 1.61% |
| March 31, 2024 | $3.44m | $12.18m | - | $217000.0 | 0.00% | 1.78% |
| Dec. 31, 2023 | $8.62m | $28.39m | - | $1.76m | 0.00% | 6.20% |
Company Impact
Help us evaluate Translate Bio Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.